Ali BÜLBÜL, Feride Füsun OKAN, Kabakoğlu Emel ÜNSÜR, Asiye NUHOĞLU

Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns

To assess clinical features, etiology, and complications in term and near-term newborns who received exchange transfusion. Materials and methods: Infants with >=35 gestational weeks admitted to our neonatal intensive care unit in the first 30 days of life and underwent exchange transfusion due to severe hyperbilirubinemia between 2002 and 2008 were included. Clinical features, etiology of hyperbilirubinemia, and complications of exchange transfusion were assessed. Results: Exchange transfusion was performed 86 times in a total of 73 patients. Eleven patients received exchange transfusion twice, and 1 patient 3 times. A great proportion of the patients (61.6%) were male, and mean (± standard deviation) gestational age and birth weight of the patients were 38.0 (1.4) weeks and 3249 (619) g, respectively. While the admission, mean total serum bilirubin levels were 27.5 (7.4) mg/dL. Hemolytic disease was found in 56.1% of the newborns (n = 41). The most common causes of hemolysis were ABO incompatibility (23.2%) and Rh sensitization (12.3%). The underlying cause was not able to be identified in 29 (39.7%) cases. The most common 2 complications were hypocalcemia (n = 7) and thrombocytopenia (n = 5). Conclusion: This study implies that no etiology was defined in nearly half of the term and near term newborns who received exchange transfusion. Despite technological advances in neonatal care units in the last decade, the blood exchange-related complication rates remained the same.

Anahtar Kelimeler:

Key words: Hyperbilirubinemia, exchange transfusion, newborn

Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns

Keywords:

Key words: Hyperbilirubinemia, exchange transfusion, newborn,

PDF

___

Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007; 120: 27-32.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1-7.
Katar S. Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia. J Pediatr Hematol Oncol 2007; 29: 284-86.
Manning D, Todd P, Maxwell M, Jane Platt M. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92: F342-46.
Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai 2005; 88: 588-92.
Abu-Ekteish F, Daoud A, Rimawi H, Kakish K, Abu-Heija A. Neonatal exchange transfusion: a Jordanian experience. Ann Trop Paediatr 2000; 20: 57-60.
Behjati S, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr 2009; DOI: 10.1007/s12098-008-0235-y.
Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr 2009; 5: 51-5.
Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396-403.
Atay E, Bozaykut A, Ipek IO. Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia. J Trop Pediatr 2006; 52: 56-8.
Bertini G, Dani C, Pezzati M, Rubaltelli FF. Prevention of bilirübin encephalopathy. Biol Neonate 2001; 79: 219-23.
Bertini G, Dani C, Tronchin M, Rubaltelli FF. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001; 107: E41.
Maisels MJ, Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics 1998; 101: 995-98.
Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6-14.
Sarici SU, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004; 113: 775-80.
Kitchen WH. Neonatal mortality in infants receiving an exchange transfusion. Aust Paediatr J 1970; 6: 30-40.
Panagopoulos G, Valaes T, Doxiadis SA. Morbidity and mortality related to exchange transfusions. J Pediatr 1969; 74: 247-54.
Weldon VV, Odel GB. Mortality risk of exchange transfusion. Pediatrics 1968; 41: 797-801.
Dikshit SK, Gupta PK. Exchange transfusion in neonatal hyperbilirubinemia. Indian Pediatr 1989; 26: 1139-45.
Guaran RL, Drew JH, Watkins AM. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol 1992; 32: 186-92.
Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure. Experiences from 1 069 newborns. Acta Paediatr Scand 1985; 74: 360-65.
Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985; 75: 417-21.
Maisels JM, Li T, Piechocki JT, Werthman MW. The effect of Exchange transfusion on serum ionized calcium. Pediatrics 1974; 53: 683-86.
Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004; 144: 626-31.